EP1248631A4 - Methods for inhibiting/treating hiv infections and aids related symptoms - Google Patents

Methods for inhibiting/treating hiv infections and aids related symptoms

Info

Publication number
EP1248631A4
EP1248631A4 EP01901750A EP01901750A EP1248631A4 EP 1248631 A4 EP1248631 A4 EP 1248631A4 EP 01901750 A EP01901750 A EP 01901750A EP 01901750 A EP01901750 A EP 01901750A EP 1248631 A4 EP1248631 A4 EP 1248631A4
Authority
EP
European Patent Office
Prior art keywords
inhibiting
methods
related symptoms
treating hiv
hiv infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01901750A
Other languages
German (de)
French (fr)
Other versions
EP1248631A1 (en
Inventor
Janos Aradi
Thomas J Bardos
Joseph A Dunn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Therex Technologies Inc
Original Assignee
Therex Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therex Technologies Inc filed Critical Therex Technologies Inc
Publication of EP1248631A1 publication Critical patent/EP1248631A1/en
Publication of EP1248631A4 publication Critical patent/EP1248631A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
EP01901750A 2000-01-06 2001-01-05 Methods for inhibiting/treating hiv infections and aids related symptoms Withdrawn EP1248631A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17466800P 2000-01-06 2000-01-06
US174668P 2000-01-06
PCT/US2001/000280 WO2001049297A1 (en) 2000-01-06 2001-01-05 Methods for inhibiting/treating hiv infections and aids related symptoms

Publications (2)

Publication Number Publication Date
EP1248631A1 EP1248631A1 (en) 2002-10-16
EP1248631A4 true EP1248631A4 (en) 2003-05-28

Family

ID=22637045

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01901750A Withdrawn EP1248631A4 (en) 2000-01-06 2001-01-05 Methods for inhibiting/treating hiv infections and aids related symptoms

Country Status (4)

Country Link
EP (1) EP1248631A4 (en)
AU (1) AU2761901A (en)
CA (1) CA2396240A1 (en)
WO (1) WO2001049297A1 (en)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO0149297A1 *

Also Published As

Publication number Publication date
CA2396240A1 (en) 2001-07-12
AU2761901A (en) 2001-07-16
WO2001049297A1 (en) 2001-07-12
WO2001049297A8 (en) 2002-02-07
EP1248631A1 (en) 2002-10-16

Similar Documents

Publication Publication Date Title
TW574392B (en) Physical vapor deposition device and method
AU3408801A (en) Tnf-alpha inhibitors
HUP0302772A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase
EP1337208A4 (en) Methods and devices for treating stuttering problems
AU5137201A (en) Rules based securities order processing
EP1337255A4 (en) Use of p38 inhibitors for the treatment of inflammation-enhanced cough
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
IL160010A0 (en) Methods and compositions for treating fungal infections
AU6387401A (en) Pyrrole derivatives for treating aids
AU2002242096A1 (en) Novel compounds and methods for inhibiting/treating hiv infections and aids related symptoms
AU2002365168A8 (en) Method and composition for treating and preventing hiv infection and aids
MXPA03005526A (en) Combination method for treating viral infections.
GB0014580D0 (en) Appatarus and process
EP1248631A4 (en) Methods for inhibiting/treating hiv infections and aids related symptoms
GB0026838D0 (en) Treatment method
AU2002221760A1 (en) Vaccine for treating allergy
HK1046848A1 (en) Specific therapeutic composition for treating aids
EP1463741A4 (en) Compounds to treat hiv infection and aids
AU2001288870A1 (en) Antiviral compounds and method of treating viral infections
AU2697401A (en) Medicament and method for treating sclerotinia infections
TW479626U (en) Treatment device for junk
EP1303281A4 (en) Methods of treatment
EP1335734A4 (en) Method for treating hiv
GB0025655D0 (en) Sludge treatment
GB0001715D0 (en) Treatment for fungal infections

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020729

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20030411

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07H 21/02 B

Ipc: 7C 07H 21/04 B

Ipc: 7A 61K 31/70 A

Ipc: 7C 07H 21/00 B

17Q First examination report despatched

Effective date: 20040617

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051125